Measuring Coverage in MNCH: Accuracy of Measuring Diagnosis and Treatment of Childhood Malaria from Household Surveys in Zambia

English version České info

Background:
To assess progress in the scale-up of rapid diagnostic tests and artemisinin-based combination therapies (ACTs) across Africa, malaria control programs have increasingly relied on standardized national household surveys to determine the proportion of children with a fever in the past 2 wk who received an effective antimalarial within 1–2 d of the onset of fever. Here, the validity of caregiver recall for measuring the primary coverage indicators for malaria diagnosis and treatment of children <5 y old is assessed.

Methods and Findings:
A cross-sectional study was conducted in five public clinics in Kaoma District, Western Provence, Zambia, to estimate the sensitivity, specificity, and accuracy of caregivers' recall of malaria testing, diagnosis, and treatment, compared to a gold standard of direct observation at the health clinics. Compared to the gold standard of clinic observation, for recall for children with fever in the past 2 wk, the sensitivity for recalling that a finger/heel stick was done was 61.9%, with a specificity of 90.0%. The sensitivity and specificity of caregivers' recalling a positive malaria test result were 62.4% and 90.7%, respectively. The sensitivity and specificity of recalling that the child was given a malaria diagnosis, irrespective of whether a laboratory test was actually done, were 76.8% and 75.9%, respectively. The sensitivity and specificity for recalling that an ACT was given were 81.0% and 91.5%, respectively.

Conclusions:
Based on these findings, results from household surveys should continue to be used for ascertaining the coverage of children with a fever in the past 2 wk that received an ACT. However, as recall of a malaria diagnosis remains suboptimal, its use in defining malaria treatment coverage is not recommended.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Measuring Coverage in MNCH: Accuracy of Measuring Diagnosis and Treatment of Childhood Malaria from Household Surveys in Zambia. PLoS Med 10(5): e32767. doi:10.1371/journal.pmed.1001417
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001417

Souhrn

Zdroje

1. Roll Back Malaria Partnership (2008) Global malaria action plan: for a malaria free world. Geneva: Roll Back Malaria Partnership.

2. Roll Back Malaria Partnership (2011) Rolling back malaria: a decade of progress in malaria control. Geneva: Roll Back Malaria Partnership.

3. World Health Organization (2010) World malaria report 2010. Geneva: World Health Organization.

4. LimSS, FullmanN, StokesA, RavishankarN, MasiyeF, et al. (2011) Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med 8: e1001091 doi:10.1371/journal.pmed.1001091.

5. Roll Back Malaria Partnership (2008) Guidelines for core population-based indicators. Geneva: Roll Back Malaria Partnership.

6. Zambia Ministry of Health (2010) Zambia national malaria indicator survey 2010. Lusaka: Zambia Ministry of Health.

7. BradburnNM, RipsLJ, ShevellSK (1987) Answering autobiographical questions: the impact of memory and inference on surveys. Science 236: 157–161.

8. ThwingJ, EiseleT, SteketeeR (2011) Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool. BMC Public Health 11: S14.

9. MEASURE DHS Demographic and Health Surveys. Available: http://www.measuredhs.com/. Accessed 14 March 2013.

10. Rutstein SO, Johnson K (2004) The DHS wealth index. Calverton (Maryland): Macro International.

11. SipilanyambeN, SimonJL, ChandaP, OlumeseP, SnowRW, et al. (2008) From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Malar J 7: 25.

12. O'ConnellKA, GatakaaH, PoyerS, NjoguJ, EvanceI, et al. (2011) Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J 10: 326.

13. HanciogluA, ArnoldF (2013) Measuring coverage in MNCH: Tracking progress in health for women and children using DHS and MICS household surveys. PLoS Med 10: e1001391 doi:10.1371/journal.pmed.1001391.

14. HazirT, BequemK, el ArifeenS, KhanAM, HuqueMH, et al. (2013) Measuring coverage in MNCH: A prospective validation study in Pakistan and Bangladesh on measuring correct treatment of childhood pneumonia. PLoS Med 10: e1001422 doi:10.1371/journal.pmed.1001422.

15. StantonCK, RawlinsB, DrakeM, AnjosM, CantorD, et al. (2013) Measuring coverage in MNCH: Testing the validity of women's self-report of key maternal and newborn health Interventions during the peripartum period in Mozambique. PLoS ONE 8: e60694 doi:10.1371/journal.pone.0060694.

16. NdiranguJ, BlandR, BarnighausenT, NewellML (2011) Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa. BMC Public Health 11: 372.

17. KrauseG, BenzlerJ, HeinmullerR, BorchertM, KoobE, et al. (1998) Performance of village pharmacies and patient compliance after implementation of essential drug programme in rural Burkina Faso. Health Policy Plan 13: 159–166.

18. FeikinDR, AudiA, OlackB, BigogoGM, PolyakC, et al. (2010) Evaluation of the optimal recall period for disease symptoms in home-based morbidity surveillance in rural and urban Kenya. Int J Epidemiol 39: 450–458.

19. LunetN, BastosJ, CumaioF, SilvaP, DiasE, et al. (2008) Recall of drug utilization depends on subtle structural questionnaire characteristics. Pharm World Sci 30: 175–181.

20. Chizema-KaweshaE, MillerJM, SteketeeRW, MukonkaVM, MukukaC, et al. (2010) Scaling up malaria control in Zambia: progress and impact 2005–2008. Am J Trop Med Hyg 83: 480–488.